As part of its regular monitoring of health-related advertising claims, the Federal Trade Commission today sent warning letters to three companies that sell oils, tinctures, capsules, “gummies,” and creams containing cannabidiol (CBD), a chemical compound derived from the cannabis plant. The letters warn the companies, which the FTC is not identifying publicly, that it is illegal to advertise that a product can prevent, treat, or cure human disease without competent and reliable scientific evidence to support such claims.
According to the Anxiety and Depression Association of America (ADAA), anxiety is far more common than people think. In fact, 40 million adults in the United States age 18 and older, or 18.1% of the population are treated for anxiety every year. Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions and it can affect people of any age. One of the best parts of decriminalizing CBD for non-prescription use is that science is finally catching up with what a lot of people have known for years, CBD helps a lot of people cope with anxiety.
We partnered with one of the best product developers in Korean beauty to bring our CBD infused sheet mask to our customers in the United States using our patent pending nanoemulsification process making our sheet masks more effective and better quality than competitors.
About a week into my jar of gummies I noticed something amazing. My hands were shaking less. My legs were twitching less. The minor fasciculations that preceded the major ones had all but vanished. I knew that CBD had been explored in the medical community as a treatment for symptoms of MS for years but I did not expect it to help me so quickly and so effectively.